PRESS RELEASE published on 04/09/2024 at 16:00, 2 years 1 month ago Gemina Labs Announces Addition to its IP Portfolio Gemina Laboratories Ltd. announces licensing of novel biosensing architecture from the University of British Columbia. The technology enables affordable high-sensitivity molecular diagnostics for infections like Mycobacterium tuberculosis Molecular Diagnostics Gemina Laboratories Ltd. Biosensing Architecture University Of British Columbia WHO Target Product Profiles
BRIEF published on 04/02/2024 at 15:05, 2 years 1 month ago Gemina Laboratories annonce un accord de licence stratégique avec Global Diagnostics Company Propriété Intellectuelle Technologie Diagnostique Laboratoires Gémina Accord De Licence Marché Mondial Du Diagnostic
BRIEF published on 04/02/2024 at 15:05, 2 years 1 month ago Gemina Laboratories Announces Strategic Licensing Agreement with Global Diagnostics Company Intellectual Property Diagnostic Technology Gemina Laboratories License Agreement Global Diagnostics Market
PRESS RELEASE published on 04/02/2024 at 15:00, 2 years 1 month ago Gemina Laboratories Sign First Strategic License Agreement Gemina Laboratories Ltd. announces license agreement with global diagnostics company, validating its technology in the in vitro diagnostics market. CEO Brian Firth highlights cost-saving potential and future partnerships Partnerships Gemina Laboratories Ltd. License Agreement Diagnostics Market Technology Validation
BRIEF published on 03/21/2024 at 14:05, 2 years 1 month ago Gemina Laboratories Ltd. annonce une mise à jour stratégique et des perspectives d'avenir Partenariats Stratégiques Licence Technologique Laboratoires Gémina Innovations Diagnostiques Diagnostic Respiratoire
BRIEF published on 03/21/2024 at 14:05, 2 years 1 month ago Gemina Laboratories Ltd. Announces Strategic Update and Future Outlook Strategic Partnerships Technology Licensing Gemina Laboratories Diagnostic Innovations Respiratory Diagnostics
PRESS RELEASE published on 03/21/2024 at 14:00, 2 years 1 month ago Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships Gemina Laboratories Ltd shares strategic update for 2024, focusing on revenue streams, partnerships, and new technologies for diagnostics. Company plans new protein production facility and market expansion Partnerships Gemina Laboratories Ltd Strategic Update Revenue Streams Protein Production Facility
BRIEF published on 03/19/2024 at 13:35, 2 years 1 month ago Gemina Completes $910,000 Convertible Note Financing Private Placement Gemina Laboratories Convertible Note Financing Biosensor Technology Diagnostic Platforms
BRIEF published on 03/19/2024 at 13:35, 2 years 1 month ago Gemina finalise un financement par billets convertibles de 910 000 $ Placement Privé Laboratoires Gémina Financement Par Billets Convertibles Technologie Des Biocapteurs Plateformes De Diagnostic
PRESS RELEASE published on 03/19/2024 at 13:30, 2 years 1 month ago Gemina Announces Closing of $910,000 Convertible Note Financing Gemina Laboratories Ltd. raises $910,000 through non-brokered private placement of unsecured convertible notes for general working capital and corporate purposes. Securities subject to holding period and outside Canada restrictions Private Placement Working Capital Securities Laws Gemina Laboratories Ltd. Unsecured Convertible Notes
Published on 05/16/2026 at 01:15, 8 hours 50 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 10 hours 5 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 10 hours 55 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 11 hours 5 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 13 hours 55 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 15 hours 55 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 16 hours 32 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 18 hours 57 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 19 hours 5 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 23 hours 55 minutes ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 1 hour ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 16 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES